source
- Boston Scientific recalls spinal cord stimulator leads after over 1,000 serious injuriesBoston Scientific announced a recall of its Infinion CX spinal cord stimulation leads after the FDA classified the action as the most serious level. The recall, issued June 17, covers all unused l…
- FDA approves AstraZeneca's new breast cancer therapyThe U.S. Food and Drug Administration has granted approval for AstraZeneca's latest breast cancer drug, expanding treatment options for patients with the disease. The approval follows a review of…